telomere diseases Telomeropathies
Conditions
Interventions
None listed
Sponsors
Erasmus MC, Universitair Medisch Centrum Rotterdam
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: Patients are diagnosed with interstitial pulmonary disease and/or a hematological disorder and must have a positive family history (meaning at least 1 relative with an interstitial pulmonary disease or hematological disorder) or Patients are diagnosed with interstitial pulmonary disease and a hematological disorder without a positive family history, Affected family members must be diagnosed with an interstitial pulmonary disease and/or a hematological disorder, Non-affected relatives and spouses will be included in the control group
Exclusion criteria
Exclusion criteria: Patients with severe physical or life threatening conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of new genetic defects associated with telomeropathies. | — |
Secondary
| Measure | Time frame |
|---|---|
| A study database and biobank for future research. | — |
Countries
Netherlands
Outcome results
None listed